Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

International Stem Cell (ISCO) Inventory Average (2016 - 2025)

International Stem Cell (ISCO) has disclosed Inventory Average for 15 consecutive years, with $1.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Inventory Average rose 12.22% to $1.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.6 million, a 12.22% increase, with the full-year FY2024 number at $1.2 million, down 8.88% from a year prior.
  • Inventory Average was $1.6 million for Q3 2025 at International Stem Cell, up from $1.4 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $1.6 million in Q3 2025 to a low of $986000.0 in Q1 2021.
  • A 5-year average of $1.3 million and a median of $1.3 million in 2023 define the central range for Inventory Average.
  • Peak YoY movement for Inventory Average: decreased 15.94% in 2021, then increased 27.08% in 2022.
  • International Stem Cell's Inventory Average stood at $1.2 million in 2021, then rose by 20.49% to $1.4 million in 2022, then decreased by 7.82% to $1.3 million in 2023, then fell by 1.82% to $1.3 million in 2024, then increased by 24.0% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for ISCO's Inventory Average are $1.6 million (Q3 2025), $1.4 million (Q2 2025), and $1.2 million (Q1 2025).